Avoralstat
Avoralstat (BCX4161) is a small molecule plasma kallikrein inhibitor developed for hereditary angioedema. It is used in research to investigate the kallikrein-kinin pathway in both in vitro biochemical assays and in vivo preclinical models of angioedema.
Product Specifications
CAS Number
918407-35-9
Product Name Alternative
Threonine proteases, Serine proteases, Ser/Thr Protease, Serine endopeptidases, plasma kallikrein (PKK), Inhibitor, hereditary, oral, inhibit, bradykinin, BCX4161, BCX-4161, BCX 4161, Avoralstat, angioedema
Field of Research
Protein Biochemistry
Purity
95.12% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.89 mM) ; DMSO:50 mg/mL (97.36 mM)
Smiles
COc1cc (c (cc1C=C) C (=O) Nc1ccc (cc1) C (N) =N) -c1ccc (nc1C (O) =O) C (=O) NCC1CC1
Molecular Formula
C28H27N5O5
Molecular Weight
513.54
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1393203 1.0 µg DNA
NAT13 sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details 
AE-322640-1 1 Kit
Rabbit Anti-Marburg (Angola) glycoprotein (GP) IgG ELISA Kit, 96 tests, Quantitative
Sign In for Pricing
View Details